In contrast, it has been reported that some breast cancers exhibit high levels of IRX2 expression [9] and that an amplification of the IRX2 genomic locus frequently coexist with an activating mutation of the PIK3CA gene in breast cancer [9], pointing also to a possible oncogenic function of the IRX2 protein in cell proliferation. Here, PIK3CA is linked to breast cancer.